A detailed history of Black Rock Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,803,477 shares of ABCL stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,803,477
Previous 3,900,564 2.49%
Holding current value
$11.1 Million
Previous $17.7 Million 36.28%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.73 - $4.73 $265,047 - $459,221
-97,087 Reduced 2.49%
3,803,477 $11.3 Million
Q1 2024

May 10, 2024

SELL
$4.29 - $5.97 $22,089 - $30,739
-5,149 Reduced 0.13%
3,900,564 $17.7 Million
Q4 2023

Feb 13, 2024

BUY
$3.91 - $5.93 $1.94 Million - $2.94 Million
496,267 Added 14.56%
3,905,713 $22.3 Million
Q3 2023

Nov 13, 2023

SELL
$4.6 - $7.95 $192,979 - $333,518
-41,952 Reduced 1.22%
3,409,446 $15.7 Million
Q2 2023

Aug 11, 2023

SELL
$5.66 - $7.59 $58 Million - $77.7 Million
-10,242,897 Reduced 74.8%
3,451,398 $22.3 Million
Q1 2023

May 12, 2023

SELL
$7.31 - $11.18 $1.15 Million - $1.76 Million
-157,707 Reduced 1.14%
13,694,295 $103 Million
Q4 2022

Feb 13, 2023

BUY
$9.48 - $14.52 $12.2 Million - $18.6 Million
1,282,862 Added 10.21%
13,852,002 $140 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $6.84 Million - $10.2 Million
743,808 Added 6.29%
12,569,140 $124 Million
Q2 2022

Aug 12, 2022

BUY
$5.72 - $10.65 $53.6 Million - $99.9 Million
9,378,033 Added 383.2%
11,825,332 $126 Million
Q1 2022

May 12, 2022

BUY
$7.46 - $14.14 $597,225 - $1.13 Million
80,057 Added 3.38%
2,447,299 $23.9 Million
Q4 2021

Feb 10, 2022

BUY
$12.99 - $17.73 $18.1 Million - $24.7 Million
1,390,655 Added 142.4%
2,367,242 $33.9 Million
Q3 2021

Nov 09, 2021

BUY
$14.85 - $21.34 $1.18 Million - $1.69 Million
79,400 Added 8.85%
976,587 $19.6 Million
Q2 2021

Aug 11, 2021

BUY
$20.19 - $34.17 $18.1 Million - $30.7 Million
897,187 New
897,187 $19.7 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.